Clinical trial
Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage…
NCT00006107 · Dana-Farber Cancer Institute, Other · Completed
Key facts
| NCT number | NCT00006107 |
|---|---|
| Title | Chemotherapy and Radiation Therapy in Treating Patients With Stage III or Stage IV Head and Neck Cancer |
| Official title | Taxotere Plus Concurrent Concomitant Boost Radiotherapy For Squamous Cell Cancer of the Head and Neck (TAXT-XRT) |
| Lead sponsor | Dana-Farber Cancer Institute, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Head and Neck Cancer |
| Intervention type | Drug, Procedure, Radiation |
| Interventions | Taxotere, Surgery, radiation therapy |
| Enrollment | 31 |
| Start date | Jul 14, 2000 |
| Primary completion | Jul 17, 2003 |
| Completion | Jul 3, 2004 |
| First posted | Jan 27, 2003 |
| Last update posted | Jun 16, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: